Merck (MRK) free cash flow was $12.4B in FY2025 (-32% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$12.4B
-32%
2024
$18.1B
+98%
2023
$9.1B
-38%
2022
$14.7B
+153%
2020
$5.8B
-42%
2019
$10.1B
+21%
2018
$8.3B
+82%
2017
$4.6B
-48%
2016
$8.8B
-22%
2015
$11.3B
+98%
2014
$5.7B
-44%
2013
$10.1B
+25%
2012
$8.1B
-24%
2011
$10.7B
+17%
2010
$9.1B
+374%
2009
$1.9B
-63%
2008
$5.3B
-12%
2007
$6.0B
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q1 2026
$2.9B
Q4 2025
$1.8B
Q3 2025
$6.8B
Q2 2025
$2.5B
Q1 2025
$1.2B
Q4 2024
$2.5B
Q3 2024
$8.5B
Q2 2024
$4.8B
Q1 2024
$2.2B
Q4 2023
-$743M
Q3 2023
$6.8B
Q2 2023
$2.7B
Source: MRK on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.